Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AUNA NYSE:CORBF NASDAQ:PSNL NASDAQ:TALK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUNAAuna$6.35-0.2%$6.30$6.05▼$9.24$470.72M2.2643,262 shs19,063 shsCORBFGlobal Cord Blood$1.05$0.96$0.25▼$1.75$127.63M-0.691,266 shs196 shsPSNLPersonalis$5.39$5.56$2.83▼$7.79$477.97M1.76811,322 shs936,173 shsTALKTalkspace$2.55-1.2%$2.58$1.76▼$4.36$432.07M1.091.14 million shs1.69 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUNAAuna-0.08%+0.55%+2.01%+0.47%-6.34%CORBFGlobal Cord Blood0.00%0.00%-22.22%0.00%-30.00%PSNLPersonalis0.00%+11.13%+19.78%-7.23%-6.59%TALKTalkspace-1.16%-3.77%+3.66%-15.00%+40.88%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUNAAuna$6.35-0.2%$6.30$6.05▼$9.24$470.72M2.2643,262 shs19,063 shsCORBFGlobal Cord Blood$1.05$0.96$0.25▼$1.75$127.63M-0.691,266 shs196 shsPSNLPersonalis$5.39$5.56$2.83▼$7.79$477.97M1.76811,322 shs936,173 shsTALKTalkspace$2.55-1.2%$2.58$1.76▼$4.36$432.07M1.091.14 million shs1.69 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUNAAuna-0.08%+0.55%+2.01%+0.47%-6.34%CORBFGlobal Cord Blood0.00%0.00%-22.22%0.00%-30.00%PSNLPersonalis0.00%+11.13%+19.78%-7.23%-6.59%TALKTalkspace-1.16%-3.77%+3.66%-15.00%+40.88%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAUNAAuna 2.33Hold$10.7068.50% UpsideCORBFGlobal Cord Blood 0.00N/AN/AN/APSNLPersonalis 3.00Buy$7.4237.60% UpsideTALKTalkspace 3.00Buy$4.5076.47% UpsideCurrent Analyst Ratings BreakdownLatest CORBF, AUNA, TALK, and PSNL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025PSNLPersonalisHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.508/6/2025PSNLPersonalisBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$6.008/6/2025PSNLPersonalisHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.50(Data available from 9/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAUNAAuna$1.17B0.40$1.17 per share5.44$5.85 per share1.09CORBFGlobal Cord Blood$196.12M0.65$0.75 per share1.40N/A∞PSNLPersonalis$84.61M5.65N/AN/A$2.87 per share1.88TALKTalkspace$187.59M2.28$0.01 per share217.15$0.69 per share3.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAUNAAuna$29.39M$0.887.228.04N/A5.49%15.14%3.60%11/18/2025 (Estimated)CORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/APSNLPersonalis-$81.28M-$1.28N/AN/AN/A-113.70%-47.57%-35.05%11/5/2025 (Estimated)TALKTalkspace$1.15M$0.02127.5613.42N/A1.41%2.48%2.11%11/4/2025 (Estimated)Latest CORBF, AUNA, TALK, and PSNL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2025Q2 2025AUNAAuna$0.13$0.33+$0.20$0.31$1.17 billion$309.00 million8/5/2025Q2 2025PSNLPersonalis-$0.25-$0.23+$0.02-$0.23$20.12 million$17.20 million8/5/2025Q2 2025TALKTalkspace$0.01-$0.00-$0.01N/A$54.08 million$54.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAUNAAunaN/AN/AN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/APSNLPersonalisN/AN/AN/AN/AN/ATALKTalkspaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAUNAAuna1.710.910.84CORBFGlobal Cord BloodN/AN/AN/APSNLPersonalisN/A6.095.92TALKTalkspaceN/A6.516.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAUNAAunaN/ACORBFGlobal Cord BloodN/APSNLPersonalis61.91%TALKTalkspace57.37%Insider OwnershipCompanyInsider OwnershipAUNAAunaN/ACORBFGlobal Cord Blood0.50%PSNLPersonalis3.80%TALKTalkspace23.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAUNAAuna14,84274.01 millionN/AN/ACORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionablePSNLPersonalis40088.68 million85.31 millionOptionableTALKTalkspace500167.47 million128.11 millionOptionableCORBF, AUNA, TALK, and PSNL HeadlinesRecent News About These CompaniesRemedy Meds acquires Thirty Madison in $500M dealSeptember 8 at 7:23 PM | mobihealthnews.comMJosh Arnold Investment Consultant LLC Acquires New Position in Talkspace, Inc. $TALKSeptember 7, 2025 | marketbeat.comTalkspace, Inc. $TALK Stock Holdings Lifted by Ancora Advisors LLCSeptember 7, 2025 | marketbeat.comNuveen LLC Buys New Holdings in Talkspace, Inc. $TALKSeptember 6, 2025 | marketbeat.comAWM Investment Company Inc. Has $10.16 Million Stock Holdings in Talkspace, Inc. $TALKSeptember 5, 2025 | marketbeat.comMetavasi Capital LP Has $2.92 Million Stock Position in Talkspace, Inc. $TALKSeptember 3, 2025 | marketbeat.comTalkspace, Inc. $TALK Shares Purchased by Vanguard Group Inc.September 1, 2025 | marketbeat.comAmerican Century Companies Inc. Sells 565,602 Shares of Talkspace, Inc. $TALKAugust 27, 2025 | marketbeat.comCore Spaces Offers Free Mental Health Services to 30,000 ResidentsAugust 25, 2025 | finance.yahoo.comTalkspace (TALK) Gets a Buy from William BlairAugust 22, 2025 | theglobeandmail.comSCHOOL PHONE BAN: Talkspace CEO speaks on teen mental health and offers tips for parentsAugust 21, 2025 | cbs6albany.comCTalkspace to Participate in Upcoming Investor ConferenceAugust 21, 2025 | globenewswire.comVoss Capital LP Sells 538,277 Shares of Talkspace, Inc. $TALKAugust 21, 2025 | marketbeat.comThe growth of mental health apps and teletherapy: why they’re so popularAugust 20, 2025 | miamitimesonline.comMCity-funded youth mental health therapy services are being used moreAugust 19, 2025 | seattletimes.comSDeutsche Bank AG Has $13.07 Million Stock Holdings in Talkspace, Inc. (NASDAQ:TALK)August 16, 2025 | marketbeat.comTALK | Talkspace Inc. Annual Income Statement | MarketWatchAugust 14, 2025 | marketwatch.comTalkspace adopts Express Access, AI-powered referral infrastructureAugust 12, 2025 | msn.comTalkspace, Inc. (NASDAQ:TALK) is NVP Associates LLC's 2nd Largest PositionAugust 11, 2025 | marketbeat.comFY2025 EPS Estimates for Talkspace Cut by Northland CapmkAugust 11, 2025 | marketbeat.comEarnings To Watch: Talkspace Inc (TALK) Reports Q2 2025 ResultAugust 6, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCORBF, AUNA, TALK, and PSNL Company DescriptionsAuna NYSE:AUNA$6.35 -0.01 (-0.16%) Closing price 09/10/2025 03:59 PM EasternExtended Trading$6.35 0.00 (0.00%) As of 09/10/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.Global Cord Blood NYSE:CORBF$1.05 0.00 (0.00%) As of 09/10/2025 03:58 PM EasternGlobal Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Personalis NASDAQ:PSNL$5.39 0.00 (0.00%) Closing price 09/10/2025 04:00 PM EasternExtended Trading$5.39 +0.00 (+0.07%) As of 09/10/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.Talkspace NASDAQ:TALK$2.55 -0.03 (-1.16%) Closing price 09/10/2025 04:00 PM EasternExtended Trading$2.55 0.00 (0.00%) As of 05:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Despite Pullback, Rocket Lab Still Looks Primed for a Breakout Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
